Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-17

Clinical Trial Update: Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries [NA]

View source ↗

Summary

Prospective randomized blinded trial evaluating VersaWrap Tendon Protector for Zone II flexor tendon injuries; trial status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VersaWrap Tendon Protector

Snippet

Sponsor: University of Florida | Conditions: Flexor Tendon | NA | Status: RECRUITING